-
Henan Grave Carved with Herbal Prescriptions Draws Hundreds of Visitors Daily
-
Ella Stiller on 'Cupertino' and Her Stance on AI
-
USMNT Coaching Search: Guardiola, Cherundolo, and Others Named as Pochettino Replacements
-
North Dakota Enacts Bipartisan Insulin Price Cap Amid National Push
-
Turkish Airlines Launches Fourth Mainland China Route to Chengdu
-
Basil Tuma Scores First Senior Goal as Malta Draws with Ten-Man Eswatini
-
RSC’s ‘Julius Caesar’ Reimagined in Women’s Prison Setting for School Tour
-
Rock & Roll Hall of Fame Inductees Announced; Attendance List Shrinks
-
Thomson Reuters Integrates CUBE Regulatory Intelligence into CoCounsel Legal
-
Road Access Completed Drill Program to Begin
-
ACCESS Newswire Continues to Repurchase its Shares
-
Greenwich LifeSciences Interview to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
-
Jaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate Updates
-
Xenetic Biosciences Reports Third Quarter 2026 Financial Results and Highlights Strategic Business Updates
-
Does IRS Debt Expire? Clear Start Tax Explains the 10-Year Collection Statute and What Quietly Resets It
-
GameSquare's Hatchet Publishes TikTok Live for Gaming in H1 2026 Report
-
Arrive AI Reports Third Quarter 2026 Results Highlighted by Revenue Growth and Expanded Partnerships
-
Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q2
-
Mako Mining Reports Q3 2026 Financial Results, Including Adjusted EBITDA(1) of US$30.3 million and EPS of US$0.19/share
-
eXoZymes to Host Third Quarter 2026 update Conference Call on Thursday, November 19, 2026
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 13
-
How Families Plan and Save for Holiday Travel
-
Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.
-
Sparta Capital Ltd. Announces Application to the Ontario Securities Commission to Become a Reporting Issuer in Ontario
-
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026
-
Rifstone Capital LLC Advances Institutional Research Platform with Expanded Global Allocation Framework
-
SMX Puts American Innovation to Work in the New Era of Artificial Intelligence
-
Sekur Private Data Raises SekurOne Price 25% to US$3,750 Per Year
-
Foundation Software Explores How Contractors Can Prepare for the AI-Driven Construction Boom
-
Jane Maciver Joins Fragrance Creators Board
-
Trustpoint Xposure Launches Program to Help Startup Founders Check How AI Search Platforms Describe Their Companies
-
DataMEDS AI Reports 50% Sequential Revenue Growth in Third Quarter 2026 From Second Quarter 2026, Delivers Net Profit Per Share of $2.72 and Provides Business Update
-
MARS Energy Group Adds Jigar Shah to Advisory Board to Accelerate Battery Storage Growth
-
The Epomaker Alice40 Brings Mahjong Sound and Sunset Style to Ergonomic Typing
-
SMX Brings American Ingenuity to the Next Frontier of Artificial Intelligence
-
Below Deck alumnus João Franco and brother arrested after fatal Turkey fight
-
Ole Miss inquiry expands after video and monkey-noise allegations
-
Thousands of Urban Homes Left Without High-Speed Internet Due to Broadband Blackspots
-
General Hospital actor Randall England dies at 75
-
Bunnie XO artwork taken down from Jelly Roll’s Nashville bar
-
London museum removes Russell Brand hair exhibit after rape conviction
-
Arlington sentinel rebukes Pete Hegseth entourage for laughter near memorial
-
Yella Beezy sentenced to life for arranging rapper Mo3’s murder
-
Kylie Jenner employee describes closet ordeal and pepper-spray incident
SWK Holdings Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
DALLAS, TX / ACCESS Newswire / March 13, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that it will issue its fourth quarter and full year 2024 earnings results after the market close on Wednesday, March 19, 2025. The Company will host a conference call to discuss its corporate and financial results on Thursday, March 20, 2025 at 10:00am ET.
The dial-in for the conference call is (888)-506-0062 or (973)-528-0011 for international callers. The participant code is 698628. A live webcast can also be accessed through the following link: https://www.webcaster4.com/Webcast/Page/3029/52109.
A replay of the conference call will be available on the SWK Holdings website shortly following the call.
About SWK Holdings Corporation
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. SWK's unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million. SWK also owns Enteris BioPharma, a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its proprietary oral drug delivery technologies. Additional information on the life science finance market is available on the Company's website at www.swkhold.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
For more information, please contact:
Investor Relations and Media
Susan Xu
[email protected]
778-323-0959
SOURCE: SWK Holdings Corp.
View the original press release on ACCESS Newswire
A.Malone--AMWN